Averica Discovery,
a Neopharm Labs company
We are an analytical development contract research organization (CRO). We work with pharmaceutical development teams to shorten timelines in the R&D process. Since our founding in 2007, we’ve developed a reputation for excellence, speed, and an ability to solve tough problems.
In late 2016, we were acquired by Neopharm Labs Inc. Based in the Montreal area, Neopharm has a 25-year history of excellence in pharmaceutical testing and analysis. In combining the two companies, we’ve developed a fully integrated platform of services capable of taking your program from preclinical stage to commercial launch.
What we do
Averica has a proven track record in providing clients with high quality materials to transition projects from discovery into development.
We offer R&D and GMP analytical services, unique preparative and analytical chromatography services (including Averica’s well-known Supercritical Fluid Chromatography platform), and a cross-border consultative project management team capable of working with your candidate or product at any stage of development or production.